Your search returned 6 results.

Results
	1.	Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial. [electronic resource] by Pearlstein, Teri B Bellew, Kevin M Endicott, Jean Steiner, Meir Publication details: Primary care companion to the Journal of clinical psychiatry 2005 In: Primary care companion to the Journal of clinical psychiatry vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A new approach to rater training and certification in a multicenter clinical trial. [electronic resource] by Kobak, Kenneth A Lipsitz, Joshua D Williams, Janet B W Engelhardt, Nina Bellew, Kevin M Producer: 20051130 In: Journal of clinical psychopharmacology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Are the effects of rater training sustainable? Results from a multicenter clinical trial. [electronic resource] by Kobak, Kenneth A Lipsitz, Joshua Williams, Janet B W Engelhardt, Nina Jeglic, Elizabeth Bellew, Kevin M Producer: 20080102 In: Journal of clinical psychopharmacology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial. [electronic resource] by Cohen, Lee S Soares, Claudio N Yonkers, Kimberly A Bellew, Kevin M Bridges, Ian M Steiner, Meir Producer: 20050404 In: Psychosomatic medicine vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. [electronic resource] by Bellew, Kevin M Pigeon, Joseph G Stang, Paul E Fleischman, William Gardner, Russell M Baker, Wilber W Producer: 20050405 In: Alzheimer disease and associated disorders vol. 18 Availability: No items available. Save to lists Add to cart (remove)
	6.	A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours. [electronic resource] by Infante, Jeffrey R Papadopoulos, Kyriakos P Bendell, Johanna C Patnaik, Amita Burris, Howard A Rasco, Drew Jones, Suzanne F Smith, Lon Cox, Donna S Durante, Michael Bellew, Kevin M Park, Joohyun Jennifer Le, Ngocdiep T Tolcher, Anthony W Producer: 20140409 In: European journal of cancer (Oxford, England : 1990) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)